Prevalence of screening in patients newly diagnosed with colorectal cancer in Ontario

Canadian Journal of Gastroenterology

Volumn 21, Issue 12, 2007, Pages 805-808

  Taylor, Chelsea ^a   Schultz, Susan E ^d   Paszat, Lawrence F ^b,d,e   Bondy, Susan ^a,d   Rabeneck, Linda ^b,c,d,e  

^a Management and Evaluation ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Cancer stage; Colorectal cancer; Screening

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ARTICLE; CANADA; CANCER SCREENING; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; FAMILY HISTORY; FEMALE; HUMAN; INTESTINE OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATIENT SELECTION; PREVALENCE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; TREATMENT INDICATION; WEIGHT REDUCTION;

EID: 39149126650     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/230420     Document Type: Article

References (15)

1. Canadian Cancer Statistics 2007. Toronto: Canadian Cancer Society/ National Cancer Institute of Canada, 2007.
2. Canadian Task Force on Preventive Health Care. Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001;165:206-8.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71,
5. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Erratum in N Engl J Med 1993;329:672).
6. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
7. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
8. Vinden C, Schultz S, Rabeneck L. ICES Research Atlas: Use of Large Bowel Procedures in Ontario, February 2004. Toronto: Institute for Clinical Evaluative Sciences, 2004.
9. Hilsden RJ. Patterns of use of flexible sigmoidoscopy, colonoscopy and gastroscopy: A population-based study in a Canadian province. Can J Gastroenterol 2004;18:213-9.
10. Cooper GS, Paynes JD. Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer 2005;103:696-701.
11. Lieberman DA, Holub J, Eisen G, Kraemer D, Morris CD. Utilization of colonoscopy in the United States: Results from a national consortium. Gastrointest Endosc 2005;62:875-83.
12. Ontario Expert Panel on Colorectal Cancer. Colorectal cancer screening: The final report of the Ontario expert panel. Toronto: Cancer Care Ontario, 1999.
13. Technical Report for the National Committee on Colorectal Cancer Screening, May 2002. (Version current at November 9, 2007).
14. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
15. Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E. Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can 2003;24:81-8.